Lupus clinical trials in Florida
23 studies for Lupus are looking for participants at sites in Florida.
Cities in Florida
- Miami10 studies
- Tampa9 studies
- Clearwater8 studies
- Plantation7 studies
- Hollywood6 studies
- Orlando5 studies
- Brandon4 studies
- Coral Springs4 studies
- Jacksonville3 studies
- Davie3 studies
- Gainesville3 studies
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Brandon
- Research Site, Miami
- Research Site, Miami
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 25, 2026 · NCT07430306A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Clinical Research Of West Florida - Phase I Unit /ID# 279292, Clearwater
- Finlay Medical Research - Greenacres /ID# 278380, Greenacres City
- Clinical Research of Osceola /ID# 278374, Kissimmee
- and 3 more
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07607964A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Arthritis & Rheumatic Disease Specialties, Aventura
- Clinical Research of West Florida 1, Clearwater
- Avanti Clinical Research Corp, Hialeah
- and 5 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07438496Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Research Site, Plantation
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 18, 2026 · NCT07201558A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- AARDS Research, Inc., Aventura
- Meris Clinical Research-Brandon-69466, Brandon
- Clinical Research of West Florida, Inc., Clearwater
- and 2 more
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Sep 17, 2026 · NCT07409181A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Omega Research Debary, LLC, DeBary
- South Florida Rheumatology, Hollywood
- GTL Medical And Research Group, Miami
- and 2 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT07355218A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- GNP Research, Cooper City
- University of Florida Clinical Research Center, Gainesville
- Miami Dermatology and Laser Research, Miami
- and 1 more
RecruitingPhase 2
Ages 12 to 70 · All sexes · Updated Sep 14, 2026 · NCT07570862A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- GNP Research at Mark Jaffe, MD, Cooper City
- Advance Medical Research Center, Miami
- Diverse Clinical Research LLC, Miami
- and 2 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 11, 2026 · NCT07332481A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Mayo Clinic, Jacksonville
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50239, Brandon
- Sl0044 50630, Clearwater
- Sl0044 50751, Coral Gables
- and 9 more
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Sep 4, 2026 · NCT06617325A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Centre for Rheumatology, Immunology and Arthritis, Fort Lauderdale
- South Florida Rheumatology, Hollywood
- LIFE Clinical Trials, Margate
- and 1 more
RecruitingObservational study
Ages 16 and older · All sexes · Updated Sep 3, 2026 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Mayo Clinic, Jacksonville
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Aug 26, 2026 · NCT06121297A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Bioresearch Partner Coral Terrace, South Miami
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 21, 2026 · NCT06570798A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 278239, Avon Park
- Clinical Research Of West Florida - Phase I Unit /ID# 275834, Clearwater
- Life Clinical Trials - Colonial Drive - Margate /ID# 276050, Margate
- and 1 more
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Aug 10, 2026 · NCT06977724Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Royal Research Corp, Hollywood
- Mayo Clinic Jacksonville, Jacksonville
- Florida Kidney Physicians, Riverview
- and 1 more
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 30, 2026 · NCT05268289A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Dolphin Medical Research, Doral
- Alloy Clinical Research LLC, Kissimmee
- SouthCoast Research Center, Miami
- and 4 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07201129A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Clearwater
- Investigative Site, DeBary
- Investigative Site, Tampa
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 27, 2026 · NCT07260877Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Clinical Res Of W Florida, Clearwater
- GNP Research, Cooper City
- IRIS Research and Development, Plantation
- and 1 more
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Jul 8, 2026 · NCT06133972A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Omega Research Group, Orlando
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jun 5, 2026 · NCT06613360A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US03-0, Clearwater
- US05-0, Orlando
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Jun 2, 2026 · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- University of Miami, Miami
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Apr 15, 2026 · NCT05934149Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
- IRIS Research and Development, LLC, Plantation
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 3, 2024 · NCT06581562From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.